Here are relevant reports on : animal-disease-diagnostics-market
-
Bioresorbable Vascular Scaffold Market by Type (Metal, Polymer), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals) and Geography – Global Forecast to 2027
The global bioresorbable vascular scaffold market size is projected to reach ~USD 75 million by 2027 from ~USD 50 million in 2022, at a CAGR of 8.5% during the forecast period. The market is driven by factors such as rapidly increasing geriatric population and the risk of coronary artery diseases and peripheral artery diseases. On the other hand, product failures and withdrawals are expected to limit market growth to a certain extent in the coming years.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029
The global peritoneal dialysis market, valued at US$9.12 billion in 2023, stood at US$9.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$12.70 billion by the end of the period. Market growth in the Asia Pacific is attributed to the rising prevalence of acute kidney diseases, improving healthcare expenditure, and the growing accessibility of dialysis for ESRD treatment.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals): Forecast to 2031
The Europe peritoneal dialysis market, valued at USD 2.12 billion in 2025, stood at USD 2.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.3% from 2026 to 2031, culminating in a forecasted valuation of USD 2.72 billion by the end of the period. The market is driven by several factors, such as increasing prevalence of chronic kidney-related diseases, strong demand for home-based dialysis, favorable reimbursement policies, and advancements in automated peritoneal dialysis (PD) systems and remote monitoring technologies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031
The US Periodontal Disease Treatment market, valued at USD 0.65 billion in 2025, stood at USD 0.68 billion in 2026 and is projected to advance at a resilient CAGR of 5.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.94 billion by the end of the period. Periodontal disease treatment in the US encompasses a wide range of technologies and solutions designed to support the diagnosis, treatment, and long-term management of gum-related conditions in dental practices.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
